Clinical Leader Live: In-House Vs. Outsource: Considerations For Biotechs

Source: Clinical Leader

Laurie Halloran, President & CEO, Halloran Consulting, joined Clinical Leader for an interactive presentation and Q&A session exploring what every small to mid-sized pharma and biotech company should consider when evaluating their outsourcing plan. During this call, Laurie discussed:

  • If your outsourcing strategy isn’t working, what should you do?
  • How are you building your internal capabilities to enable programs that facilitate longer term program support?
  • What new approaches are you engaging to enable data-driven innovation to play a role in supporting more efficient drug development?
  • Is your current outsourcing operating model too rigid to experiment with the cutting-edge technology when its efficiency drives margins down for the CROs?

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader